New publication on Bactiguard Wound Care – positive results with Hydrocyn Aqua treatment

In a recent publication in the journal Wounds Asia (2023, Volume 6, Issue 1), treatment of chronic wounds with Bactiguard Wound Care’s Hydrocyn Aqua showed good results. Five patients with different types of chronic wounds were treated with Hydrocyn Aqua. The wound healing process was documented by photographing the wound and measuring its...

First-in-man clinical study with Bactiguard coated trauma implants published

Good outcome for severe open fractures when treated with Bactiguard coated trauma implants, first-in-man study shows Fracture-related infections are a feared post-operative complication with dire consequences for the patient and high costs for the healthcare systems. It may lead to nail failure, revision surgeries, nail removal and in certain...

We can prevent sepsis and save lives

Every year at least 11 million deaths globally are caused by sepsis, which always starts with an infection. Sepsis is the number one preventable cause of death in world. To raise awareness about how to prevent and identify signs of sepsis, World Sepsis Days takes place. Sepsis is the number one preventable cause of death in the world, but very...

More than 50% risk reduction of ventilator associated pneumonia with Bactiguard’s Technology

A new study from Liège, Belgium, shows that the usage of Bactiguard’s infection preventive endotracheal tube reduces ventilator associated pneumonia (VAP) with 53% in intensive care patients. The study VITAL was presented in the beginning of October at the European Society of Intensive Care Medicine Congress (ESICM) where it was selected as one...

Impact of COVID-19 on healthcare associated infections

A new American study concludes that healthcare associated infections (HAI) increased in the US during the COVID-19 pandemic. Infections related to the urinary tract, respiratory tract and blood stream all raised, for instance, central line associated bloodstream infections (CLABSI) increased with 46-47%. The intention of the study was to...

Healthcare acquired infections increase the mortality during Covid-treatment

Overuse of antibiotics and superbugs could be worsening the Covid-19 pandemic in India, according to an Indian Council of Medical Research (ICMR) study of 10 hospitals. The study showed that more than half of the Covid-19 patients who get a secondary bacterial or fungal infection die. Covid-19 mortality worldwide is 10 %, the subgroup of patients...

This is how Bactiguard helps prevent infections and save lives

Antibiotic resistance is one of the most acute health risks of our time. The threat is often referred to as "the silent tsunami" and could potentially nullify hundreds of years of medical progress, according to the WHO. To counteract the resistance, we need to prevent infections in healthcare and in our everyday lives - a challenge for which the...

46% of critically ill COVID-19 patients developed HAI according to new study

A recent Italian publication has studied hospital-acquired infections (HAI) in critically ill COVID-19 patients. 774 patients with COVID-19 treated at intensive care unit (ICU) at 8 hospitals in Italy were included. The publication1 shows that 46 % of the critically ill COVID-19 patients developed HAI, of which 38 % were caused by multi-drug...

Bactiguard proud founder and member of Vision Zero initiative for India

Yesterday the first joint working group of the “Healthcare associated infection – Vision zero for India” platform was held. Significant progress was made in the journey towards establishing a solid platform for reaching the goal of “zero healthcare-associated infections (HAI)” in India. The initiative is built on a triple helix model...

The Economist paints a scary vision of the future

In an imagined scenario from 2041 the Economist describes how the world belatedly responded to antimicrobial resistance. If antibiotics stop working, the superbugs will spread rapidly. According to a study published in the scientific journal The Lancet1 in November 2018 more than 33,000 people die in Europe every year as a direct consequence of...

Minister Lena Hallengren mentions Bactiguard as an good example in India

In an interview with Times of India, Lena Hallengren, the Swedish minister of Social Affairs mentions Bactiguard as one of the Swedish companies contributing to developing the healthcare sector in India. On a delegation trip to India the national magazine Times of India made an interview with the Swedish minister of Social Affairs, Lena...

Play the interactive WHO game to learn more about antibiotics

The on-going annual World Antibiotic Awareness Week is a WHO initiative to put antibiotic resistance (AMR) in the spotlight and increase awareness. It also aims to encourage best practices to avoid the further emergence and spread of AMR. Now everyone can learn more trough an interactive game developed by the WHO. Our time with antibiotics is...

Bactiguard supports the Swedish foundation Prematurföreningen Mirakel

Modern, advanced healthcare is dependent on effective antibiotics. But incorrect and excessive use of antibiotics has allowed resistant bacteria to spread rapidly throughout the world. If this development doesn’t halt, common infections will be hard to treat and even become incurable. Premature care is an example where multi-resistant bacteria...

Bactiguard supports the World Sepsis Day, September 13th

Sepsis remains the primary cause of death from infections around the world, despite advances in modern medicine such as vaccines and antibiotics. Every 3-4 seconds someone dies of sepsis. The World Sepsis Day is held on September 13th every year and is an opportunity for people across the world to unite in the fight against sepsis. Bactiguard is...

Patients prefer Bactiguard in Swedish study

Yesterday at the ongoing "Urologidagarna" (Urology Days), arranged by the Swedish Urological Society, a Swedish study was presented about Bactiguard's Infection Protection Foley Catheter Silicone (BIP Foley). The study shows that 28 out 31 patients, who switched from a standard catheter to the BIP Foley Catheter, felt that the change led to both...

The World Health Organization adopts resolution to fight sepsis

On 26 May 2017, the World Health Organization (WHO) agreed on a resolution to improve the prevention, diagnosis and treatment of sepsis. The resolution urges governments to strengthen their policies in infection prevention and to decrease the spread of antimicrobial resistance. The resolution itself focuses on the following key preventive actions:...

Bactiguard sponsors World Sepsis Day

Bactiguard is now a proud sponsor of World Sepsis Day initiated by the Global Sepsis Alliance. Sepsis is the main cause of death from infection and affects more than 30 million people a year; of whom 6 to 8 million die. In Sweden, almost 40,000 people suffer from sepsis per year.[1] Surviving patients suffer from the consequences for the rest of...

At war without an army

In Life Science Sweden Issue No 1 March 2017, Bactiguard’s CEO Christian Kinch presents our simple idea: Preventing Health Care related infections caused by medical devices. Read the article

Bactiguard launches tool to reduce healthcare associated infections

Urinary tract infections resulting from the use of indwelling urinary catheters are one of the most common healthcare associated infections, causing patient suffering and a large financial strain on healthcare systems. These infections can also result in more serious complications such as bloodstream infections with high mortality rates. These...

APIC International Infection Prevention Week (IIPW)

This week is the annual International Infection Prevention Week (IIPW), , and aims to raise awareness of the role infection prevention plays in improving patient safety. IIPW is organized by the US-based Association for Professionals in Infection Control and Epidemiology (APIC) which is the leading professional association for infection...

Recognizing the 5th World Sepsis Day

World Sepsis Day, on September 13, is a collaborative project organized by the Global Sepsis Alliance and relevant non-governmental stakeholders with the aim of raising awareness on one of the most common yet least-recognized illnesses. Sepsis is the main cause of death from infection and kills more people than cancer in the developed world.[1]...

Developing a new generation of catheters

Bactiguard and BioInteractions have received a European research grant aimed at developing a new generation of vascular access catheters, with new bio-smart materials for medical devices. The technology will be developed in a joint project with BioInteractions, UK and Bactiguard, financed by VINNOVA and Innovate UK. Some of the most serious...

The EAU congress was beyond all expectations

About three hundred urologists visited Bactiguard’s booth at EAU, Europe’s biggest congress for doctors specialized in urology. Several of them expressed a great need for a solution reducing the number of catheter associated urinary tract infections (CAUTI), which often occur when patients are using a urinary catheter for a longer time. During...

Infection prevention to reduce the healthcare costs in Colombia

The healthcare costs in Colombia are increasing and the need for infection control, such as Bactiguard’s infection preventive solution, is becoming a more prioritized area. In February Bactiguard and Business Sweden jointly visited Colombia aiming to network and establish relationships with decision makers and potential customers in the...

Bactiguard’s coating may be applied on hemodialysis catheters

The annual World Kidney Day is arranged on March 10, to increase awareness about the chronic kidney disease, which is a worldwide disease affecting millions of patients. In connection to this, the newspaper The Parliament Magazine has published several articles about kidney diseases, including a presentation the DIREKT project, also involving...

Bactiguard won a tender in the Swedish region Halland

Bactiguard won a tender, to supply urinary tract catheters to the Swedish region Halland. This means that Halland is able to start to purchase Bactiguard’s Infection Protection Foley catheters from 1 October 2016. ”In the past year we have been working methodically to demonstrate the value of our technology and our infection prevention urinary...

First order from China

Following the Chinese approval of Bactiguard’s Foley catheters for infection prevention, which was recently announced, the company has received an initial order of 100,000 catheters. In January 2016, the doors were opened to China, one of the largest and fastest growing markets in the world, with the approval of the company’s Foley catheter...

Peru delegation with a view to cooperation

This week, Bactiguard hosted a Peruvian healthcare delegation, studying the benefits of the Swedish triple helix model, i.e. the interaction between the healthcare system, academia and industry. The Peruvian delegation, organized by Business Sweden, consisted of representatives of the Ministry of Health and doctors from the National Cancer...

Top researchers, hospital managers and companies in joint effort to combat infectious disease

The 11th edition of the Swedish American Life Science Summit in Stockholm took place on August 19-21, gathering scientists, doctors, industry representatives and investors from around the world. The main purpose of the annual conference is to create business opportunities and exchange ideas between the participants, transforming research to...

Meet Bactiguard’s innovator Billy Södervall

Billy Södervall acquired his interest in chemistry and pharmacy early on. He started teaching chemistry and then he went over to working with heat pumps at NIBE AB, where he created the innovation that formed the foundation for Bactiguard. Billy always felt his work was also his hobby, explaining why his garage at home in Markaryd is converted...

Things to consider before travelling

It´s summer time, vacation is approaching and many travel abroad. If you are planning a trip, there are some things to consider to be on the safe side. Hospital acquired infections (HAI) and the spread of multi resistant bacteria is a global problem affecting us all, where we live and while travelling you expose yourself to an increased risk of...

Antimicrobial resistance – people at risk of dying of common infections

Every year, as many as 500 000 people die from common infections, as they can no longer be treated with antibiotics due to antimicrobial resistance. This situation also has an impact on the economy, with a cost of about 1.5 billion euro for increased healthcare cost and loss of productivity in the EU alone. And the problem is steadily growing....

Save lives – Clean Your Hands

Good hand hygiene is essential to avoid infections and can reduce healthcare associated infections and, most important of all, save millions of lives. Today May 5 is the annual Save Lives: Clean your hands campaign, initiated by the World Health Organization (WHO) aiming to increase awareness about the importance of hand hygiene in order to save...

Bactiguard is ready to combat HAI in Romania

Healthcare associated infections (HAI) are common in Romania, like in the rest of the world. Ventilator associated pneumonia (VAP) is a particularly serious condition, which Bactiguard’s technology can prevent. Together with our distributor Alpha Medical, we are well equipped to prevent and combat this severe problem in Romania. This week we...

Ten million people at risk if antimicrobial resistance isn’t tackled

Infectious diseases, caused by antibiotic resistant bacteria, are a steadily increasing problem around the world. The consequences are huge, both from a human and economic perspective. If action is not taken, about ten million lives are at risk and cost is expected to reach above 100 trillion USD in 2050. This is stated in the report “Review on...

Kick off for Latin America

Latin America and the imminent sales start in Chile and Brazil was the focus of Bactiguard’s attention in the second week of October. In March 2014, Bactiguard signed an exclusive distribution agreement with Promedon for Argentina, Brazil, Chile and Mexico and now, two of these markets are ready to launch. A two-day interactive sales training...

The Bactiguard technology, our most important asset

The Bactiguard technology has been clinically proven to reduce catheter-related urinary tract infections and is by far the most well documented and effective technology that I know of, says Dr William R Jarvis, one of the authors behind the most recently performed study and previously active at the CDC for many years. Bactiguard has a patented...

Article in China Daily about Bactiguard – December 10th 2013

Innovative coating makes hospitals healthier Bactiguard started in 2005 with one mission: to reduce hospital-acquired infections (HAI) transmitted through medical devices. Its innovative technology is based on the Swedish industrialist Gustaf Dalén’s Nobel Prize-winning research from 1912, on automatic regulators for use in conjunction with gas...

Healthcare Associated Infections can be prevented

Health Care Assoicated Infections can be prevented. Watch this movie http://www.youtube.com/watch?v=yYpKESbVYvI&feature=youtu.be to see how the Bactiguard coating prevents bacteria and saves lives !

Bactiguard reduces hospital acquired infections in Sweden by up to 40 percent

Bactiguard is now starting to supply its own urinary catheter, BIP Foley, to the Swedish healthcare system, with the goal of radically reducing one of medical care’s most difficult problems – unnecessary suffering and, in certain cases, premature death due to hospital acquired infections (HAI), also known as nosocomial infections. BIP Foley...